PNI building exterior
Resources

A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma.

  • External Link

A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma.

Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca R, O’Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS. Clin Cancer Res. 2019 Jul 18. pii: clincanres.0261.2019. doi: 10.1158/1078-0432.CCR-19-0261. [Epub ahead of print]

PMID: 31320597

Similar articles (https://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&from_uid=31320597)

Learn More